Dataset: Transcription profiling of mouse embryonic stem cell line Sox1Tv2 during neuronal differentiation
[u'This experiment is part of the FunGenES project (FunGenES - Functional Genomics in Embryonic Stem Cells partially funded by the 6th...
[u'This experiment is part of the FunGenES project (FunGenES - Functional Genomics in Embryonic Stem Cells partially funded by the 6th Framework Programme of the European Union, ', {u'a': {u'href': u'http://www.fungenes.org', u'target': u'_blank', u'$': u'http://www.fungenes.org'}}, u'). The experiment was conducted at Aventis Pharma, Paris, France. Goal of the experiment is the characterisation of gene expression profile during neuronal differentiation of Sox1Tv2 ES cells in the embryoid body protocol. Materials and methods:Sox1Tv2-E14 derived ES cells have been cultured without serum in liquid culture in order to form embryoid bodies. A 48 hour retinoic acid stimulation has been applied between days 4 and 6 (EB6) for half the samples. After 8 days of differentiation (EB8), EBs have been dissociated and cells plated on poly-D-lysine/laminin coated dishes and cultured in differentiation medium. bFGF has been added to the culture medium during the first 2 days after plating (N2). After removal of bFGF, cells were allowed to differentiate for 4 more days (N6). Protocol described in FunGenES handbook. Relationships between samples: Different time points during differentiation process: ES, EB3, EB4, EB6 (ctl and RA), EB8 (ctl and RA), N2 (ctl and RA), N6 (ctl and RA),Treatments: Retinoic acid treatment: EB4 to EB6bFGF addition (10ng/ml final): postplating to N2. Culture conditions: Liquid medium culture: GMEM + KOSR Differentiation medium: DMEM/F12 and NBM medium with N2 and B27 supplements.']
- Species:
- mouse
- Samples:
- 42
- Source:
- E-TABM-669
- Updated:
- Dec.12, 2014
- Registered:
- Nov.21, 2014
Sample | Age(d) | Compound |
---|---|---|
AVEF-1_fe1_0es_01 | E14+0 days | control |
AVEF-1_fe1_0es_01 | E14+0 days | control |
AVEF-1_fe1_0es_01 | E14+0 days | control |
AVEF-1_fe1_0es_01 | E14+0 days | control |
AVEF-1_fe1_eb3_01 | E14+3 days | control |
AVEF-1_fe1_eb3_01 | E14+3 days | control |
AVEF-1_fe1_eb3_01 | E14+3 days | control |
AVEF-1_fe1_eb3_01 | E14+3 days | control |
AVEF-1_fe1_eb4_03 | E14+4 days | control |
AVEF-1_fe1_eb4_03 | E14+4 days | control |
AVEF-1_fe1_eb6ctl_01 | E14+6 days | control |
AVEF-1_fe1_eb6ctl_01 | E14+6 days | control |
AVEF-1_fe1_eb6ctl_01 | E14+6 days | control |
AVEF-1_fe1_eb6ctl_01 | E14+6 days | control |
AVEF-1_fe1_eb6ra_01 | E14+6 days | retinoic acid and bFGF |
AVEF-1_fe1_eb6ra_01 | E14+6 days | retinoic acid and bFGF |
AVEF-1_fe1_eb6ra_01 | E14+6 days | retinoic acid and bFGF |
AVEF-1_fe1_eb6ra_01 | E14+6 days | retinoic acid and bFGF |
AVEF-1_fe1_eb8ctl_01 | E14+8 days | control |
AVEF-1_fe1_eb8ctl_01 | E14+8 days | control |
AVEF-1_fe1_eb8ctl_01 | E14+8 days | control |
AVEF-1_fe1_eb8ctl_01 | E14+8 days | control |
AVEF-1_fe1_eb8ra_01 | E14+8 days | retinoic acid and bFGF |
AVEF-1_fe1_eb8ra_01 | E14+8 days | retinoic acid and bFGF |
AVEF-1_fe1_eb8ra_01 | E14+8 days | retinoic acid and bFGF |
AVEF-1_fe1_eb8ra_01 | E14+8 days | retinoic acid and bFGF |
AVEF-1_fe1_n2ctl_01 | E14+10 days | control |
AVEF-1_fe1_n2ctl_01 | E14+10 days | control |
AVEF-1_fe1_n2ctl_01 | E14+10 days | control |
AVEF-1_fe1_n2ctl_01 | E14+10 days | control |
AVEF-1_fe1_n2ra_01 | E14+10 days | retinoic acid and bFGF |
AVEF-1_fe1_n2ra_01 | E14+10 days | retinoic acid and bFGF |
AVEF-1_fe1_n2ra_01 | E14+10 days | retinoic acid and bFGF |
AVEF-1_fe1_n2ra_01 | E14+10 days | retinoic acid and bFGF |
AVEF-1_fe1_n6ctl_01 | E14+14 days | control |
AVEF-1_fe1_n6ctl_01 | E14+14 days | control |
AVEF-1_fe1_n6ctl_01 | E14+14 days | control |
AVEF-1_fe1_n6ctl_01 | E14+14 days | control |
AVEF-1_fe1_n6ra_01 | E14+14 days | retinoic acid and bFGF |
AVEF-1_fe1_n6ra_01 | E14+14 days | retinoic acid and bFGF |
AVEF-1_fe1_n6ra_01 | E14+14 days | retinoic acid and bFGF |
AVEF-1_fe1_n6ra_01 | E14+14 days | retinoic acid and bFGF |